Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI

被引:11
作者
Beckmann, N
Gentsch, C
Baumann, D
Bruttel, K
Vassout, A
Schoeffter, P
Loetscher, E
Bobadilla, M
Perentes, E
Rudin, M
机构
[1] Novartis Pharma AG, Core Technol Area, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Nervous Syst Dept, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Dept Toxicol, CH-4002 Basel, Switzerland
关键词
corticotropin-releasing factor (CRF); magnetic resonance imaging (MRI); microimaging; transgenic mouse; stress;
D O I
10.1002/nbm.704
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
High resolution magnetic resonance imaging (MRI) was applied to quantify alterations in thymus and adrenal volumes, as well as body fat in genetically engineered corticotropin-releasing factor (CRF)-overexpressing mice. When compared to the organs in age-matched wild-type animals, the adrenals in CRF-overexpressing male mice were significantly enlarged and the thymus volume in females was significantly smaller. The fat content was significantly larger in CRF-overexpressing mite. The anatomical alterations observed in the MRI studies were in perfect line with post-mortem data (weights of organs). Furthermore, the observed interstrain differences are in agreement with recently published data on (i) the effect of continuous, intraventricular infusion of CRF in rats and (ii) the presence of atrophic adrenals in CRF-knockout mice. The present studies demonstrate that MRI can provide reliable measures of relatively small structures such as the adrenal glands and the thymus in mice. This makes MRI an attractive, non-terminal tool to monitor in laboratory animals, including transgenic mice, the consequence of continuous stress on relevant organs. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:210 / 216
页数:9
相关论文
共 27 条
[21]   DEVELOPMENT OF CUSHINGS-SYNDROME IN CORTICOTROPIN-RELEASING FACTOR TRANSGENIC MICE [J].
STENZELPOORE, MP ;
CAMERON, VA ;
VAUGHAN, J ;
SAWCHENKO, PE ;
VALE, W .
ENDOCRINOLOGY, 1992, 130 (06) :3378-3386
[22]   CORTICOTROPIN-RELEASING FACTOR MODULATES DEFENSIVE-WITHDRAWAL AND EXPLORATORY-BEHAVIOR IN RATS [J].
TAKAHASHI, LK ;
KALIN, NH ;
VANDENBURGT, JA ;
SHERMAN, JE .
BEHAVIORAL NEUROSCIENCE, 1989, 103 (03) :648-654
[23]   COMPARISON OF ADRENOCORTICAL ZONATION IN C57BL/6J AND DDD MICE [J].
TANAKA, S ;
MATSUZAWA, A .
EXPERIMENTAL ANIMALS, 1995, 44 (04) :285-291
[24]   CHARACTERIZATION OF A 41-RESIDUE OVINE HYPOTHALAMIC PEPTIDE THAT STIMULATES SECRETION OF CORTICOTROPIN AND BETA-ENDORPHIN [J].
VALE, W ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J .
SCIENCE, 1981, 213 (4514) :1394-1397
[25]   Animal models of CRH deficiency [J].
Venihaki, M ;
Majzoub, JA .
FRONTIERS IN NEUROENDOCRINOLOGY, 1999, 20 (02) :122-145
[26]  
Weishaupt D, 1999, Curr Opin Urol, V9, P153, DOI 10.1097/00042307-199903000-00010
[27]   Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated [J].
Zobel, AW ;
Nickel, T ;
Künzel, HE ;
Ackl, N ;
Sonntag, A ;
Ising, M ;
Holsboer, F .
JOURNAL OF PSYCHIATRIC RESEARCH, 2000, 34 (03) :171-181